Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 14, 5 (2008)
doi:10.1038/nm0108-5
Survey hints at uneven adoption of cancer vaccine
Barbara Boughton1
- Philadelphia
When public health experts learned about the arrival of Gardasil, the first vaccine approved by the US Food and Drug Administration to protect against cancer, many of them enthusiastically endorsed it. Since then, however, the vaccine has been dogged by political controversy.
To read this story in full you will need to login or make a payment (see right).
